This useful study explores the role of RAP2A in asymmetric cell division (ACD) regulation in glioblastoma stem cells (GSCs), drawing parallels to Drosophila ACD mechanisms and proposing that an ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

A laser used in cosmetic dermatology for nearly 40 years showed properties similar to those seen with other types of lasers.

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

"Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer," said Joachim Aerts, M.D., a LUNAR investigator and Professor of Pulmonary ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using ...

Several components of the hedgehog (Hh) pathway are crucial to basal cell carcinoma (BCC) tumorigenesis. Primary cilia have emerged as key organelles in Hh signal transduction in mammalian systems ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Now visualized using cryo-electron microscopy, the carrier’s lock-like mechanism could be the key to tackling diseases like cancer, diabetes ... it needs to be transferred inside the cell’s ...

A new discovery could pave the way for more effective cancer treatment by helping certain ... to improve their ability to slip through cell membranes by passive diffusion. But the new strategy ...

researchers delivered 7.7 to 22.3 times more of the drug inside cancer cells, making the treatment up to 23 times more potent than before, according to the study published April 17 in Cell.

they were able to deliver between 7.7 and 22.3 times more of the drug into cancer cells – making the treatment up to 23 times more effective, according to a study published today (April 17) in Cell.